Science Explorer Interactive view Map
Topic · Hematology

Multiple Myeloma Research and Treatments

Multiple Myeloma Research and Treatments is a research topic within Hematology. Science Explorer counts 33k research works in it since 1950. 13.8% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the diagnosis, staging, treatment, and molecular classification of multiple myeloma. It covers topics such as the International Myeloma Working Group criteria, novel therapies including proteasome inhibitors and immunomodulatory drugs, autologous transplantation, genomic abnormalities, and the role of the bone marrow microenvironment in disease progression.

  • International Myeloma Working Group
  • Diagnosis Criteria
  • Staging System
  • Novel Therapies
  • Autologous Transplantation
  • Genomic Abnormalities
  • Proteasome Inhibitors
  • Immunomodulatory Drugs
  • Minimal Residual Disease
  • Bone Marrow Microenvironment
Research works
33k
fractional, since 1950
In the world top 10%
4.6k
per year above
Top-10% rate
13.8%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
+32%
the tick is no change

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Multiple Myeloma Research and Treatments research?

By volume, the United States and China publish the most (2.5k and 1.1k works in 2022–2025).

By volume, 2022–2025

  1. 1 United States 2.5k works
  2. 2 China 1.1k works
  3. 3 Italy 320 works
  4. 4 Germany 297 works
  5. 5 India 275 works
  6. 6 Spain 264 works
  7. 7 Japan 263 works
  8. 8 United Kingdom 255 works
  9. 9 France 246 works
  10. 10 Brazil 158 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 43.6%China: 19.8%Italy: 5.6%Germany: 5.2%6 others listed: 25.8%44%largest
United States2,465 · 43.6%China1,118 · 19.8%Italy320 · 5.6%Germany297 · 5.2%6 others listed1,460 · 25.8%

Shares of the rows listed above, not of the whole node.

Which institutions lead Multiple Myeloma Research and Treatments research?

By volume in 2022–2025, The University of Texas MD Anderson Cancer Center publishes the most Multiple Myeloma Research and Treatments research, followed by Memorial Sloan Kettering Cancer Center and National and Kapodistrian University of Athens.

By volume, 2022–2025

  1. 1 The University of Texas MD Anderson Cancer CenterUnited States 76 works
  2. 2 Memorial Sloan Kettering Cancer CenterUnited States 60 works
  3. 3 National and Kapodistrian University of AthensGreece 52 works
  4. 4 Mayo Clinic in ArizonaUnited States 51 works
  5. 5 Dana-Farber Cancer InstituteUnited States 47 works
  6. 6 Mayo ClinicUnited States 42 works
  7. 7 Moffitt Cancer CenterUnited States 40 works
  8. 8 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 39 works
  9. 9 Cleveland ClinicUnited States 37 works
  10. 10 Icahn School of Medicine at Mount SinaiUnited States 37 works

Who are the leading researchers in Multiple Myeloma Research and Treatments?

The most-cited researchers publishing on Multiple Myeloma Research and Treatments include Benjamin L. Ebert, Gad Getz and Ettore Beghi.

  1. 1 Benjamin L. Ebert United States 6.7k citations
  2. 2 Gad Getz United States 6.2k citations
  3. 3 Ettore Beghi Italy 4.6k citations
  4. 4 Hagop M. Kantarjian United States 4k citations
  5. 5 Caroline Robert France 3.3k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

Where is Multiple Myeloma Research and Treatments research done?

The largest centres of Multiple Myeloma Research and Treatments research in 2022–2025 are New York (United States), Beijing (China), Boston (United States) and Houston (United States). Among places with at least 20 works in it, it is an unusually large share of all research in Hopewell.

Largest cities, 2022–2025

  1. 1 New York United States 208 works
  2. 2 Beijing China 171 works
  3. 3 Boston United States 123 works
  4. 4 Houston United States 102 works
  5. 5 London United Kingdom 98 works
  6. 6 Shanghai China 95 works
  7. 7 Paris France 81 works
  8. 8 Tokyo Japan 78 works
  9. 9 Seoul South Korea 76 works
  10. 10 Guangzhou China 74 works

Where it is the local speciality

  1. HopewellUS · 21.8 works80×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Multiple Myeloma Research and Treatments than the world average.

See Multiple Myeloma Research and Treatments on the map

Where is the best place to study Multiple Myeloma Research and Treatments?

Among universities, judged by research, Icahn School of Medicine at Mount Sinai, National and Kapodistrian University of Athens and Xuzhou Medical College score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%30%mean 17.59%fractional works in this node (log) →share in the world top 10% →Icahn School of Medicine at Mount Sinai: 37, 21.8%National and Kapodistrian University of Athens: 52, 15.6%Xuzhou Medical College: 13, 24.0%Medical College of Wisconsin: 24, 15.3%Providence College: 10, 17.4%University of Arkansas for Medical Sciences: 26, 15.2%Harvard University: 35, 25.8%Emory University: 35, 15.9%Chinese Academy of Medical Sciences & Peking Union Medical College: 38, 7.9%University of Miami: 21, 17.0%Xuzhou Medical CollegeIcahn School of Medi…National and Kapodis…Medical College of W…
above the meannear itbelow it

One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.

#UniversityScoreTop 10%SpecialisationWorksGrowth
1 Icahn School of Medicine at Mount SinaiUnited States 71.421.8%10.7×37 +153.4%
2 National and Kapodistrian University of AthensGreece 64.115.6%14.7×52 +57.4%
3 Xuzhou Medical CollegeChina 61.824.0%8.8×13 +485.5%
4 Medical College of WisconsinUnited States 58.715.3%13.0×24 +123.3%
5 Providence CollegeUnited States 54.117.4%17.3×10 +132.8%
6 University of Arkansas for Medical SciencesUnited States 52.215.2%25.1×26 +2.1%
7 Harvard UniversityUnited States 51.525.8%3.9×35 +13.0%
8 Emory UniversityUnited States 50.015.9%7.1×35 +31.6%
9 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 49.67.9%5.6×38 +218.1%
10 University of MiamiUnited States 46.117.0%6.0×21 +71.7%

Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.

Is Multiple Myeloma Research and Treatments research growing?

Output in 2018–2022 was 32% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Multiple Myeloma Research and Treatments.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.